Rocket One Inc.
RKTO
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.71M
Close$
$0.45
10.8% downside
Current Fair Value
10.8% downsideOvervalued by 10.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.71 Million |
|---|---|
| Enterprise Value | $6.82 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.9 |
| Beta | 0.91 |
| Outstanding Shares | 20,547,977 |
Return
| Return on Equity | -162.43% |
|---|---|
| Return on Assets | -138.98% |
| Return on Invested Capital | -160.57% |
Valuation & Multiples
| P/E Ratio | -0.79 |
|---|---|
| PEG | -1.07 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.52 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.15
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hoth Therapeutics Inc
6 employees
CEO: Robbie Knie Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering fr...